In our study, we used FFPE tissue samples from n = 127 HNSCC patients treated with primary chemoradiation in order to investigate the potential relevance of 3q oncogene SEC62 as an indicator of patient outcome and response to therapy. The gene discussed is SEC62; the disease is head and neck squamous cell carcinoma.